Question

Difficulty: MediumDiagnostic Workup and Test Sequencing

A 62-year-old woman presents to the emergency department with a 24-hour history of severe, intermittent right upper quadrant abdominal pain that radiates to her right scapula. She also reports several episodes of nausea and vomiting. She has no prior history of similar pain and has not had any recent illnesses. Her temperature is 37.4°C (99.3°F), blood pressure is 132/84 mmHg, heart rate is 88/min, and respiratory rate is 16/min. On physical examination, the abdomen is non-distended. There is moderate tenderness to deep palpation in the right upper quadrant, but no guarding, rigidity, or rebound tenderness. Murphy sign is negative. There is no scleral icterus or visible jaundice.

Laboratory studies show:
White blood cell count: 8,500/mm³
Total bilirubin: 2.2 mg/dL
Direct bilirubin: 1.6 mg/dL
Alkaline phosphatase: 245 U/L
Aspartate aminotransferase (AST): 140 U/L
Alanine aminotransferase (ALT): 165 U/L
Lipase: 42 U/L

A right upper quadrant transabdominal ultrasound reveals multiple gallstones within the gallbladder. The gallbladder wall thickness is 2 mm, and there is no pericholecystic fluid. The common bile duct measures 9 mm in diameter, but no obstructing stones are visualized within the duct.

Which of the following is the most appropriate next step in the diagnostic workup?

  1. Magnetic resonance cholangiopancreatographyAnswer
  2. B
    Endoscopic retrograde cholangiopancreatography
  3. C
    Computed tomography of the abdomen with intravenous contrast
  4. D
    Hepatobiliary iminodiacetic acid scintigraphy
  5. E
    Discharge home with scheduled outpatient cholecystectomy

Answer

Magnetic resonance cholangiopancreatography
The correct answer is magnetic resonance cholangiopancreatography (MRCP). This patient presents with symptoms of biliary colic, abnormal liver chemistries (elevated bilirubin, AST, ALT, and alkaline phosphatase), and a dilated common bile duct (CBD) on ultrasound without a visualized stone. This clinical picture places her at intermediate risk (10-50% probability) for choledocholithiasis. According to clinical guidelines, the most appropriate next step for intermediate-risk patients is non-invasive imaging of the biliary tree using MRCP or endoscopic ultrasound (EUS). This step confirms the presence of a CBD stone before proceeding to an invasive therapeutic procedure.

Step-by-Step Solution

1
Evaluate the patient's clinical presentation, laboratory results, and initial imaging.
The patient has symptomatic right upper quadrant pain, elevated liver chemistries, an elevated total bilirubin of 2.2 mg/dL, and a dilated common bile duct (9 mm) on ultrasound without a visualized stone or acute cholecystitis.
Initial assessment is necessary to determine the risk of choledocholithiasis based on established guidelines.
2
Apply risk stratification criteria for choledocholithiasis.
The patient meets criteria for intermediate risk (10-50% probability) due to the presence of a dilated common bile duct and abnormal liver biochemistries. She does not meet high-risk criteria (e.g., bilirubin > 4 mg/dL with a dilated duct, a visualized stone, or clinical ascending cholangitis).
Risk stratification dictates the optimal sequencing of further diagnostic and therapeutic interventions.
3
Determine the most appropriate next step in management based on the assigned risk level.
For intermediate-risk patients, non-invasive imaging of the biliary tree is indicated.
Magnetic resonance cholangiopancreatography (MRCP) or endoscopic ultrasound (EUS) confirms the presence of a stone before subjecting the patient to the procedural risks of an invasive test like ERCP.

Key Concept

Patients at intermediate risk for choledocholithiasis (e.g., abnormal liver chemistries, dilated common bile duct without a visualized stone) should undergo non-invasive evaluation with magnetic resonance cholangiopancreatography (MRCP) or endoscopic ultrasound (EUS) prior to invasive procedures.
Rate this question